These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15572424)
1. Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone. Hanifi-Moghaddam P; Gielen SC; Kloosterboer HJ; De Gooyer ME; Sijbers AM; van Gool AJ; Smid M; Moorhouse M; van Wijk FH; Burger CW; Blok LJ J Clin Endocrinol Metab; 2005 Feb; 90(2):973-83. PubMed ID: 15572424 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro estrogenic and progestagenic actions of Tibolone. Sadarangani A; Salgado AM; Kato S; Pinto M; Carvajal A; Monso C; Owen GI; Vigil P Biol Res; 2005; 38(2-3):245-58. PubMed ID: 16238103 [TBL] [Abstract][Full Text] [Related]
3. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line. Hanifi-Moghaddam P; Sijmons B; Ott MC; van Ijcken WF; Nowzari D; Kuhne EC; van der Spek P; Kloosterboer HJ; Burger CW; Blok LJ J Mol Endocrinol; 2006 Dec; 37(3):405-13. PubMed ID: 17170081 [TBL] [Abstract][Full Text] [Related]
4. Progestagenic effects of tibolone are target gene-specific in human endometrial cells. Zhang W; Mazella J; Kloosterboer HJ; Tseng L J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988 [TBL] [Abstract][Full Text] [Related]
5. Receptor profiling and endocrine interactions of tibolone. de Gooyer ME; Deckers GH; Schoonen WG; Verheul HA; Kloosterboer HJ Steroids; 2003 Jan; 68(1):21-30. PubMed ID: 12475720 [TBL] [Abstract][Full Text] [Related]
6. Progestogenic effects of tibolone on human endometrial cancer cells. Blok LJ; De Ruiter PE; Kühne EC; Hanekamp EE; Grootegoed JA; Smid-Koopman E; Gielen SC; De Gooyer ME; Kloosterboer HJ; Burger CW J Clin Endocrinol Metab; 2003 May; 88(5):2327-34. PubMed ID: 12727992 [TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium. Mirkin S; Archer DF Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063 [TBL] [Abstract][Full Text] [Related]
8. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism. Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141 [TBL] [Abstract][Full Text] [Related]
9. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone. Falany JL; Falany CN Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling. Hanifi-Moghaddam P; Boers-Sijmons B; Klaassens AH; van Wijk FH; den Bakker MA; Ott MC; Shipley GL; Verheul HA; Kloosterboer HJ; Burger CW; Blok LJ J Mol Med (Berl); 2007 May; 85(5):471-80. PubMed ID: 17226044 [TBL] [Abstract][Full Text] [Related]
11. Effects of tibolone metabolites on human endometrial cell lines in co-culture. Barbier C; Kloosterboer HJ; Kaufman DG Reprod Sci; 2008 Jan; 15(1):75-82. PubMed ID: 18212357 [TBL] [Abstract][Full Text] [Related]
12. Tissue-selectivity: the mechanism of action of tibolone. Kloosterboer HJ Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246 [TBL] [Abstract][Full Text] [Related]
13. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen. Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477 [TBL] [Abstract][Full Text] [Related]
14. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor. Ederveen AG; Kloosterboer HJ J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. Markiewicz L; Gurpide E J Steroid Biochem; 1990 Apr; 35(5):535-41. PubMed ID: 2355729 [TBL] [Abstract][Full Text] [Related]
16. Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone. Bianco-Miotto T; Trotta AP; Need EF; Lee AM; Ochnik AM; Giorgio L; Leach DA; Swinstead EE; O'Loughlin MA; Newman MR; Birrell SN; Butler LM; Harris JM; Buchanan G Mol Cell Endocrinol; 2014 Feb; 382(2):899-908. PubMed ID: 24239616 [TBL] [Abstract][Full Text] [Related]
17. Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina. Hanifi-Moghaddam P; Boers-Sijmons B; Klaassens AH; van Wijk FH; Van Ijcken WF; Van der Spek P; Verheul HA; Kloosterboer HJ; Burger CW; Blok LJ Hum Reprod; 2008 Feb; 23(2):298-305. PubMed ID: 18077316 [TBL] [Abstract][Full Text] [Related]
18. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells. Mirkin S; Mahony MC; Archer DF Menopause; 2004; 11(1):82-8. PubMed ID: 14716187 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the endometrium in patients treated with tibolone. Yazigi R; Sahid S; Contreras L; Rodriguez T Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984 [TBL] [Abstract][Full Text] [Related]
20. Effects of tibolone on nuclear receptors in human endometrial cells. Zhang W; Mazella J; Kloosterboer HJ; Tseng L Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]